International Harrington Prize Jointly Awarded to Drs. Warren Leonard and John O’Shea

The eighth annual Harrington Prize for Innovation in Medicine has been jointly awarded to Warren J. Leonard, MD, NHLBI, NIH Distinguished Investigator, and John J. O’Shea, MD, Scientific Director, NIAMS, NIH, for their respective contributions to the field of immunology, from fundamental discovery to therapeutic impact.

Read more

Harrington Discovery Institute Announces New Fund to Advance Breakthrough Discoveries into Novel Treatments

The transatlantic, not-for-profit medical accelerator, Harrington Discovery Institute (HDI) at University Hospitals, has collaborated with leading venture investor, Advent Life Sciences (‘Advent’) in the launch of the Advent-Harrington Impact Fund. Advent’s new impact fund, structured alongside Advent Life Sciences Fund III, brings a total of $215 million to advance breakthrough discoveries into novel treatments for the benefit of patients and society.

Read more

University Hospitals Portage Medical Center Opens Food for Life Market

University Hospitals (UH) Portage Medical Center is opening a UH Food for Life Market to set patients up for success in nutrition and dietary education. The UH Food for Life Market is part of a holistic approach to addressing food insecurity and the medical conditions, including chronic health conditions, that are impacted by nutrition and access to healthy food.

Read more

University Hospitals Richmond Medical Center Physician Brings New Wound Healing Technology to Ohio

University Hospitals (UH) Richmond Medical Center is the first clinical setting in Ohio to utilize a special technology that sends acoustic sound waves to wounds to jump start the healing process. Windy Cole, DPM, Certified Wound Specialist Physician at the Center for Wound Care at UH Richmond Medical Center, is leading the use of the novel device in the state through research and case studies.

The dermaPACE® System from SANUWAVE, is an FDA approved device indicated for treatment of diabetic foot ulcers. The device delivers acoustic shock waves to tissues, helping to jump start wound healing through new blood vessel formation.

Read more

Iowa and Ohio Researchers Discover New, Protective Strategy for Embryonic Development during Prenatal Stress in Animal Model

New research from the University of Iowa and University Hospitals Cleveland Medical Center demonstrates that offspring can be protected from the effects of prenatal stress by administering a neuroprotective compound during pregnancy.

Read more

UH East Region Community Hospitals Collaborate with Greater Cleveland Food Bank to Provide Hunger-Free Holidays

University Hospitals (UH) east region community hospitals are collaborating with the Greater Cleveland Food Bank to provide hunger-free holidays for families in need.

Donation boxes will be placed at UH Ahuja, Bedford, Conneaut, Geauga, Geneva, Portage and Richmond Medical Center entrances from December 1 through December 15. Caregivers can voluntarily bring non-perishable food items when they report to work, and UH EMS vehicles will be transporting donations to the food bank.

Because of COVID-19 precautions, community members who are not employees cannot enter the hospitals; however, to make donating easy for the community, UH and the Greater Cleveland Food Bank have developed a virtual food drive for monetary donations. Just one dollar can provide four nutritious meals, so donations of all sizes go a long way: www.greaterclevelandfoodbank.org/UH2020.

Read more

University Hospitals Ahuja Medical Center’s Medical Executive Committee Donates $20,000 to Organizations in Need

Amidst the global COVID-19 pandemic this year, University Hospitals (UH) Ahuja Medical Center’s Medical Executive Committee donated to two organizations in need. The committee provided $10,000 to the Greater Cleveland Food Bank. A donation of just one dollar provides enough food for four nutritious meals, meaning this donation helped give 40,000 meals to those in need.

Read more

Researchers Discover Neuroprotective Treatment for Chronic Traumatic Brain Injury

Traumatic brain injury (TBI) is a leading cause of cognitive impairment that affects millions of people worldwide. Despite growing awareness about the debilitating and lifelong progressive consequences of TBI, there are currently no treatments that slow the deteriorative process. TBI survivors are currently treated with extensive physical and cognitive rehabilitation, accompanied by medications that may mitigate symptoms yet do not halt or slow neurodegeneration. Now, researchers have found for the first time that this process can be pharmacologically reversed in an animal model of this chronic health condition, offering an important proof of principle in the field and a potential path to new therapy.

Read more

University Hospitals Cleveland Medical Center Joins the Cardiometabolic Center Alliance as a Key Strategic Partner and Charter Member

The Cardiometabolic Center Alliance (CMCA), founded by Saint Luke’s Mid America Heart Institute is pleased to announce the addition of University Hospitals Cleveland Medical Center as Key Strategic Partner and Charter Member. As a coalition that seeks to establish Cardiometabolic Centers of Excellence nationwide aimed at transforming the treatment of type 2 diabetes (T2D) and related cardiovascular (CV) and renal comorbidities, the CMCA considers University Hospitals (UH) a large integrated health system based in Cleveland, Ohio a key member of the Alliance.

Read more

New Research Shows Air Pollution Could Play a Role in Development of Cardiometabolic Diseases, Diabetes

Air pollution is the world’s leading environmental risk factor, and causes more than nine million deaths per year. New research published in the Journal of Clinical Investigation shows air pollution may play a role in the development of cardiometabolic diseases, such as diabetes. Importantly, the effects were reversible with cessation of exposure.

Read more

UH to launch clinical trial in the fight to protect clinicians against COVID-19

University Hospitals announced it will lead a clinical trial that involves the administration of an investigational drug, ARMS-I, to its caregivers working on the frontlines of the COVID-19 pandemic. The trial, named the ARMS-I COVID Study, is designed to assess whether the drug helps prevent airborne transmission of coronavirus and whether it reduces the symptoms of healthcare providers who have tested positive for the virus.

Read more

University Hospitals Ahuja Medical Center Physician First in Ohio to Use Wound Care Imaging Device in Clinical Setting

University Hospitals Ahuja Medical Center (UH) is the first clinical setting in Ohio using special technology to identify harmful bacteria, leading to healing for patients suffering from chronic wounds. Windy Cole, DPM, Medical Director of the UH Ahuja Wound Care Center, conducted research studies utilizing the MolecuLight i:X® and is leading the use of the novel device in the state.

Read more